Form D · Pharmaceuticals
Karyopharm Therapeutics Inc.
Newton, MA · CIK 0001503802
Offering snapshot reported Dec 8, 2022 · SEC filing
- Reported sold
- $165M Offering amount: $165M
- Investors reported
- 33 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 7, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 8, 2022 | Initial | $165,000,003 | No comparison | 33 | SEC filing |
| Aug 1, 2013 | Initial | $18,999,996 | No comparison | 7 | SEC filing |
| May 1, 2013 | Initial | $20,500,000 | No comparison | 8 | SEC filing |
| Nov 5, 2010 | Initial | $700,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $9.9M
- Finders' fees
- $0
- Form D file number
- 021-466961
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Jefferies LLC | 2347 | |
| Piper Sandler & Co. | 665 | |
| Barclays Capital, Inc. | 19714 | |
| Robert W. Baird & Co. Incorporated | 8158 | |
| H.C. Wainwright & Co. LLC | 375 |
Source: Form D, filed Dec 8, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alan Barber | Executive |
| Garen G. Bohlin | Director |
| Paul Brannelly | Executive |
| Sohanya Cheng | Executive |
| Ronald De Pinho | Director |
| Barry E. Greene | Director |
| Peter Honig | Director |
| Michael Kauffman | Director, Executive |
| Michael Mano | Executive |
| Michael Mason | Executive |
| Mansoor Raza Mirza | Director |
| Stephen Mitchener | Executive |
| Christy J. Oliger | Director |
| Deepika R. Pakianathan | Director |
| Richard Paulson | Director, Executive |
| Stuart Poulton | Executive |
| Reshma Rangwala | Executive |
| Chen Schor | Director |
| Sharon Shacham | Executive |
| Kenneth E. Weg | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
85 Wells Avenue Second Floor
Newton, MA, 02459
Newton, MA, 02459